3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1
1
Status
Completed
15
Recruiting
7
Active not recruiting
4
Withdrawn
3
Unknown
2
Not yet recruiting
2
Suspended
1
Sponsor Class
NIH
12
OTHER
6
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Lymphoid
2
Other hematologic neoplasm
1
Conditions
Neoplasms
183
Breast Neoplasms
174
Carcinoma, Non-Small-Cell Lung
173
Colorectal Neoplasms
105
Stomach Neoplasms
81
Pancreatic Neoplasms
79
Lung Neoplasms
79
Prostatic Neoplasms
77
Melanoma
68
Neoplasm Metastasis
67
Recurrence
66
Leukemia, Myeloid, Acute
66
Multiple Myeloma
64
Ovarian Neoplasms
62
Carcinoma, Hepatocellular
62
Lymphoma
61
Advanced Solid Tumor
61
Advanced Solid Tumors
56
Solid Tumor
50
Uterine Cervical Neoplasms
48
Lymphoma, Non-Hodgkin
48
Glioblastoma
44
Lymphoma, B-Cell
40
Leukemia
39
Colonic Neoplasms
34
Precursor Cell Lymphoblastic Leukemia-Lymphoma
33
Head and Neck Neoplasms
33
Esophageal Neoplasms
32
Urinary Bladder Neoplasms
30
Sarcoma
30
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
INDUSTRY
×
Dendritic Cell Sarcoma, Interdigitating
×
Clear all
NCT05487651
2023-05-18
ANCHOR2
Athenex, Inc.
Phase 1
Unknown
36 enrolled
NCT00846157
2011-06-28
NKCell
NKBio Co.Ltd.
Phase 3
Unknown
276 enrolled